Case Report

Adrenal Ganglioneuroblastoma in Adults: A Case Report and Review of the Literature

Table 2

International Neuroblastoma Risk Group Consensus Pretreatment Classification Scheme.

INRG StageAge (months)INPC groupGrade of differentiationMYCN gene11q aberrationPloidyPretreatment risk group

L1/L2GN maturing; GNB intermixedVery low

L1
Localized tumor confined to one body compartment and with absence of image-defined risk factors
Any, except GN maturing or GNB intermixedNA
Amplified
Very low
High

L2
Locoregional tumor with presence of one or more image-defined risk factor
<18Any, except GN maturing or GNB intermixedNANoLow
YesIntermediate
≥18 GNB nodular; NBDifferentiatingNANoLow
Yes Intermediate
Poorly differentiated or undifferentiatedNA
AmplifiedHigh

M
Distant metastatic disease (except MS)
<18NAHyperploidLow
<12NADiploidIntermediate
12–18NADiploidIntermediate
<18AmplifiedHigh
≥18High

MS
Metastatic disease confined to skin, liver, and/or bone marrow in children <18 months
NAnoVery low
yesHigh
AmplifiedHigh

INRG: International Neuroblastoma Risk Group; INCP: International Neuroblastoma Pathology Classification; GN = ganglioneuroma; GNB = ganglioneuroblastoma; NB = neuroblastoma; NA: not amplified; modified from Cohn et al. [11].